Short-term safety of the BNT162b2 mRNA COVID-19 vaccine in patients with cancer treated with immune checkpoint inhibitors
Barliz Waissengrin, Abed Agbarya, Esraa Safadi, Hagit Padova, Ido Wolf
Topics & Concepts
Coronavirus disease 2019 (COVID-19)MedicineCancerImmune systemTerm (time)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakImmunologyVirologyCancer researchInternal medicineDiseaseInfectious disease (medical specialty)OutbreakQuantum mechanicsPhysicsCOVID-19 and healthcare impactsCancer Immunotherapy and BiomarkersCOVID-19 Clinical Research Studies